Oxybutynin Tablets
Indicated to support to mitigate urinary incontinence symptoms, developed to alleviate bladder spasms and improve patient comfort.
Strengths: 2.5 · 5mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Ditropan
- Therapeutic class
Antimuscarinic agent
- Pharmacological class
Antispasmodic
- Precautions and warnings
may cause drowsiness; avoid in hot weather due to risk of heatstroke
- Minor side effects
dry mouth; dizziness; constipation
- Moderate side effects
blurred vision; nausea; headache
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Sanofi
- Onset Time
1 hour
- Duration
6–10 hours
- Storage instructions
Store below 25°C in a safe place.
- Drug interactions
antihistamines; antipsychotics; antidepressants
- Age restrictions
Use with caution in children.
Contraindications
myasthenia gravis; severe gastrointestinal conditions; urinary retention; narrow-angle glaucoma
Serious side effects
urinary retention — requires immediate medical attention; tachycardia — requires immediate medical attention
Patient summary
Indicated to support to mitigate urinary incontinence symptoms, developed to alleviate bladder spasms and improve patient comfort.
Mechanism of action
Oxybutynin exerts a direct antispasmodic effect on smooth muscle and inhibits the muscarinic action of acetylcholine on smooth muscle, thereby relaxing the bladder detrusor muscle.
Pregnancy and breastfeeding
Pregnancy: Use only if clearly necessary. Breastfeeding: Excreted in breast milk; avoid use.
Oxybutynin Tablets
Indicated to support to mitigate urinary incontinence symptoms, developed to alleviate bladder spasms and improve patient comfort.
Editorial Notes
- Active ingredient(s): Oxybutynin
- Listed indication(s): Urinary Incontinence, Overactive Bladder
Usually available as
- 180 tablets - 2.5 mg1193-2-5-mg-14117
- 90 tablets - 5 mg1193-5-mg-14121